Cardiac Biotech Solutions Inc. (CBSC)

Cardiac Biotech Solutions Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Sep 16, 2026	Mar 31, 2018	Mar 31, 2017
Market Capitalization	6	17	100
Market Cap Growth	-6.25%	-82.86%	-
Last Close Price	0.04	0.30	1.75

Price Ratios

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Sep 16, 2026	Mar 31, 2018	Mar 31, 2017
PS Ratio	123.17	467.94	3032.81
PB Ratio	-4.49	-14.11	-192.88

Financial Efficiency

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Sep 16, 2026	Mar 31, 2018	Mar 31, 2017
Net Debt / Equity Ratio	0.01	0.00	0.02
Net Debt / EBITDA Ratio	-	0.00	0.03
Net Debt / FCF Ratio	-	0.01	0.20
Asset Turnover	-	0.57	-
Inventory Turnover	-	0.70	-
Quick Ratio	0.01	0.01	0.03
Current Ratio	0.03	0.02	0.07
Return on Assets (ROA)	-	-1103.12%	-
Return on Capital Employed (ROCE)	54.20%	93.20%	71.40%

Yields

Fiscal Year	Current	FY 2018	FY 2017
Period Ending	Sep 16, 2026	Mar 31, 2018	Mar 31, 2017
Earnings Yield	-10.32%	-6.60%	-0.39%
FCF Yield	-12.45%	-4.51%	-0.06%
Buyback Yield / Dilution	-	-1.52%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 5, 2019

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 12, 2026

Data Sources Report a data error